Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.4K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.4K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

2.0K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
2.0K
Frequency-dependent Selection01:21

Frequency-dependent Selection

23.9K
When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
23.9K
Predator-Prey Interactions02:39

Predator-Prey Interactions

21.5K
Predators consume prey for energy. Predators that acquire prey and prey that avoid predation both increase their chances of survival and reproduction (i.e., fitness). Routine predator-prey interactions elicit mutual adaptations that improve predator offenses, such as claws, teeth, and speed, as well as prey defenses, including crypsis, aposematism, and mimicry. Thus, predator-prey interactions resemble an evolutionary arms race.
21.5K
Responses to Salt Stress02:02

Responses to Salt Stress

14.6K
Salt stress—which can be triggered by high salt concentrations in a plant’s environment—can significantly affect plant growth and crop production by influencing photosynthesis and the absorption of water and nutrients.
14.6K
Comparative Excretory Systems02:24

Comparative Excretory Systems

26.6K
Animals have evolved different strategies for excretion, the removal of waste from the body. Most waste must be dissolved in water to be excreted, so an animal’s excretory strategy directly affects its water balance.
26.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in Australia.

Journal of paediatrics and child health·2021
Same author

Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective.

American journal of preventive cardiology·2021
Same author

Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians.

Internal medicine journal·2021
Same author

Improving detection and management of familial hypercholesterolaemia in Australian general practice.

Heart (British Cardiac Society)·2021
Same author

Ankylosing Spondylitis and Risk of Cardiac Arrhythmia and Conduction Disorders: A Systematic Review and Meta-analysis.

Current cardiology reviews·2021
Same author

Effectiveness of proprotein convertase subtilisin/kexin-9 monoclonal antibody treatment on plasma lipoprotein(a) concentrations in patients with elevated lipoprotein(a) attending a clinic.

Clinical cardiology·2021
Same journal

SBK2 Links Cardiac Stress Signaling to Mitochondrial Proteostasis.

Circulation research·2026
Same journal

Myeloid Piezo1 as a Brake on Efferocytosis and Cardiac Repair in the Infarcted Heart.

Circulation research·2026
Same journal

Targeting Late Na<sup>+</sup> Current: Too Late or Better Late Than Never?

Circulation research·2026
Same journal

HFpEF-Any: Human Single-Nuclear Transcriptomics Challenging the Translational Validity of Current HFpEF Models.

Circulation research·2026
Same journal

Myovascular Niche: The Role of Endothelial Cells in Skeletal Muscle Health and Disease.

Circulation research·2026
Same journal

Meet the First Authors.

Circulation research·2026
See all related articles

Related Experiment Video

Updated: Jan 30, 2026

Measuring RAN Peptide Toxicity in C. elegans
10:49

Measuring RAN Peptide Toxicity in C. elegans

Published on: April 30, 2020

7.1K

Statin Toxicity.

Natalie C Ward1,2, Gerald F Watts2,3, Robert H Eckel4

  • 1From the School of Public Health, Curtin University, Perth, Western Australia, Australia (N.C.W.).

Circulation Research
|January 18, 2019
PubMed
Summary
This summary is machine-generated.

Lowering LDL cholesterol with statins significantly reduces cardiovascular risk. However, statin-associated muscle symptoms often lead to discontinuation, highlighting the need for alternative strategies and risk identification.

Keywords:
atherosclerosischolesterolhyperlipidemiariskstatin

More Related Videos

Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

13.9K
Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products
05:27

Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products

Published on: December 25, 2016

15.6K

Related Experiment Videos

Last Updated: Jan 30, 2026

Measuring RAN Peptide Toxicity in C. elegans
10:49

Measuring RAN Peptide Toxicity in C. elegans

Published on: April 30, 2020

7.1K
Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

13.9K
Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products
05:27

Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products

Published on: December 25, 2016

15.6K

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Lowering low-density lipoprotein cholesterol (LDL-c) is crucial for reducing cardiovascular morbidity and mortality.
  • Statins are widely prescribed for cholesterol management but face challenges with patient adherence and discontinuation.
  • Statin-associated muscle symptoms (SAMS) are a primary reason for treatment cessation, impacting atherosclerotic cardiovascular disease prevention.

Purpose of the Study:

  • To review the mechanisms and clinical significance of statin toxicity.
  • To focus on the evaluation and management of statin-associated muscle symptoms.
  • To identify individuals at higher risk for statin side effects and explore alternative treatments.

Main Methods:

  • Literature review of statin mechanisms, toxicity, and side effects.
  • Analysis of clinical importance and patient adherence data.
  • Focus on diagnostic and therapeutic strategies for statin-induced muscle symptoms.

Main Results:

  • Overwhelming evidence supports LDL-c lowering for cardiovascular risk reduction.
  • Statin discontinuation due to side effects, particularly muscle symptoms, remains a significant barrier.
  • Understanding and managing statin toxicity is essential for effective cardiovascular disease prevention.

Conclusions:

  • Effective LDL-c reduction is vital for cardiovascular health.
  • Addressing statin-associated muscle symptoms is critical for improving adherence and treatment outcomes.
  • Further research into mechanisms and alternative therapies is needed to optimize statin use.